Retrospective cohort study on the relationship between Metformin and the risk of dementia in patients with type 2 diabetes mellitus
10.3969/j.issn.1006-6187.2024.08.002
- VernacularTitle:二甲双胍与2型糖尿病患者痴呆症发病风险相关性的回顾性队列研究
- Author:
Houyu ZHAO
1
;
Sanbao CHAI
;
Yexiang SUN
;
Peng SHEN
;
Hongbo LIN
;
Siyan ZHAN
;
Feng SUN
Author Information
1. 400030 重庆大学医学院
- Keywords:
Diabetes mellitus,type 2;
Metformin;
Dementia
- From:
Chinese Journal of Diabetes
2024;32(8):567-575
- CountryChina
- Language:Chinese
-
Abstract:
Objective To assess the association between Metformin use and the risk of dementia in patients with type 2 diabetes mellitus(T2DM).Methods The research data came from the big medical data platform of Yinzhou District,and we constructed a cohort of T2DM patients who had initiated treatment of Metformin or sulfonylurea since January 1,2009.The inverse probability of treatment weighting(IPTW)was used to control the baseline confounding factors,and the Cox regression model was used to estimate the HR(95%CI)of the association between Metformin use and dementia risk.Results The incidence rate of dementia in new users of Metformin(41181 persons)and sulfonylureas(38092 persons)was 128.4 per 100000 person years and 142.3 per 100000 person years respectively.Compared with sulfonylureas,the crude analysis with no adjustment for confounding factors showed that there was a negative association between the use of Metformin and the incidence of dementia,with an HR(95%CI)0.930(0.800～1.090).After adjusting for potential confounders with IPTW,Metformin was not significantly associated with the risk of dementia HR(95%CI)1.040(0.890～1.220).The subgroup analysis results for different baseline characteristics were consistent with the primary analysis results,and there were no statistically significant associations between Metformin and dementia incidence risk in all subgroups.Conclusions There is no significant association between the use of Metformin and the risk of dementia in T2DM patients in the Yinzhou District.
